Psychotropic Stewardship Program

Protect Your Residents and Your Bottom Line

With new surveyor guidance effective October 24, 2022, it’s clear psychotropic use is a continued focus of CMS. Take steps to promote appropriate use of these medications to lower regulatory risk, reduce adverse events, and enhance residents’ mental, physical, and psychosocial well-being with our Psychotropic Stewardship Program.

October 24, 2022, CMS Updated Guidance highlights


Psychotropic Stewardship icon

of long-term care residents are taking a psychotropic, as per the U.S. Department of Health and Human Services.


binder cover for 2024 psychotropic stewardship program

Zero & Low-Cost Components of the Psychotropic Stewardship Program Include:

  • Digital version available to download from ViewMasteRx or printed program binder available to order
  • Implementation guide to introduce the program to your staff
  • CDC Core Elements to evaluate current practices
  • Sample psychotropic policies and procedures
  • Resources and training materials to support P&Ps
  • Consultant pharmacist expertise in reviewing psychotropic medication regimens*


*Additional consultant pharmacist support is also available, including for prospective consultations and retrospective audits.


Compliance Guidance for Psychotropic Medication Pharmacy-related F-Tags

Learn the top F-Tags for this drug class to be aware of and guidance for long-term care facilities.

Read More

Need More Help?

Stay ahead of the curve with our customizable program! Contact your Consultant Pharmacist today to find out more about accessing PharMerica’s Psychotropic Stewardship Program.